About
Founded in 1965, Adimmune is the first in Taiwan to comply with GMP standards of the FDA and the EU
COMPANY PROFILE
PIC/S GMP Manufacturer
Founded in 1965, Adimmune Corporation is the only influenza vaccine manufacturer with both EU GMP and US FDA certificates in Taiwan. Our major products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, Japanese Encephalitis Vaccine (JEV), Tetanus Toxoid, and purified Tuberculin.
Technical Cooperation
Throughout history, Adimmune had technical cooperation with partners such as Kitasato Daiichi Sankyo, Japan’s largest vaccine research and manufacturer (formerly known as Kitasato Institute), and Crucell (now Johnson & Johnson) in the Netherlands. We recently signed a memorandum of understanding with the top manufacturer of injection needles and syringes, Becton Dickinson (The United States).
A Leading Supplier of Biologics in the Asia-Pacific Region
Adimmune supports Sanofi Pasteur (France) in the commercialization of the recombinant protein quadrivalent influenza vaccine in the United States. We also cooperate with Shenzhen Techdow (China) to produce low-molecular enoxaparin sodium. The capacity further enlarges to other areas as our Cell Culture Production Plant received Taiwan FDA GMP Certificate in 2022, making Adimmune the only certificated vaccine company in the country.
Outstanding Player in the Vaccine Industry
Adimmune has been at the frontline of epidemic prevention. We have supplied more than 30 million doses of AdimFlu-S (QIS), our own influenza vaccine, to meet the domestic demand in Taiwan. The subsequent export to China and Southeast Asia witnessed our global recognition. We continue to develop recombinant protein subunit vaccines, and cell-cultured products.
A Leading Supplier of Biologics in the Asia-Pacific Region
Looking forward, Adimmune aspires to develop high-quality, high-efficacy, and eco-friendly biomedical products. The ultimate goal is to become a leading bio-pharmaceutical company in the Asia-Pacific region and a leader of Taiwan’s biotechnology industry.